Bio-Rad Laboratories

BIONYSE United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$9.636 B

$360.40 -2.04%

Close of 9 Oct 2026

As of 9 Oct 2026, Bio-Rad Laboratories (BIO) has a market capitalization of $9.64B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.58B

#997 by revenue

Earnings

$759.9M

#474 by earnings

Shares outstanding

26,852,000

Latest filing cover page

P/E ratio

12.7

Cap ÷ net income

Other share classes

Bio-Rad Laboratories lists more than one class of stock. Company figures above cover all classes combined.

BIO-B

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →

#5AvantorAVTR$10.4B
#610x GenomicsTXG$10.1B
#7Bio-Rad LaboratoriesBIO$9.64B
#8BrukerBRKR$8.82B
#9Alamar BiosciencesALMR$1.80B

What if Bio-Rad Laboratories were worth as much as…

Open the what-if tool →

Gold $29.1T

$1,086,905

Per share 3,016× higher

Bitcoin $1.66T

$62,105.21

Per share 172× higher

Nvidia $5.55T

$207,739.23

Per share 576× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Bio-Rad Laboratories are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.